651 – 660 of 1279
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Method comparison study of the Elecsys® β-Amyloid (1–42) CSF assay versus comparator assays and LC-MS/MS
(
- Contribution to journal › Article
-
Mark
Prevalence of dementia diagnosis not otherwise specified in eight European countries A cross-sectional cohort study
(
- Contribution to journal › Article
-
Mark
Prevalence of dementia diagnoses not otherwise specified in eight European countries: a cross-sectional cohort study
2019) The International Association of Gerontology and Geriatrics European Region Congress 2019 (IAGG-ER) p.01-25(
- Contribution to conference › Abstract
-
Mark
Bättre behandlad Alzheimers sjukdom kan öka tiden att bo hemma
(
- Contribution to specialist publication or newspaper › Specialist publication article
-
Mark
Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer’s Disease
(
- Contribution to journal › Scientific review
-
Mark
Association of Neuropathologically Confirmed Frontotemporal Dementia and Alzheimer Disease With Criminal and Socially Inappropriate Behavior in a Swedish Cohort
2019) In JAMA Network Open(
- Contribution to journal › Article
-
Mark
Galectin-3, a novel endogenous TREM2 ligand, detrimentally regulates inflammatory response in Alzheimer’s disease
(
- Contribution to journal › Article
-
Mark
18
F-Flortaucipir in TDP-43 associated frontotemporal dementia
(
- Contribution to journal › Article
-
Mark
Mapping of apparent susceptibility yields promising diagnostic separation of progressive supranuclear palsy from other causes of parkinsonism
(
- Contribution to journal › Article
-
Mark
Amyloid PET and cognitive decline in cognitively normal individuals : the SCIENCe project
(
- Contribution to journal › Article